NASDAQ
No price data available for this timeframe.
Akebia Therapeutics, Inc. (AKBA) has a interest coverage ratio of 0.97x as of Wednesday, July 15, 2026. This represents a 113.47% increase compared to its 12-month average of -7.22x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.